Citation Impact
Citing Papers
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>
2003 Standout
Postmenopausal osteoporosis: patient choices and outcomes
1995
Child abuse: Adolescent records vs. adult recall
1990 Standout
Health benefits of physical activity: the evidence
2006 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Osteoporosis
2019 Standout
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics
2011 Standout
Relaxant effects of the essential oil of Ocimum gratissimum on isolated ileum of the guinea pig
2002
Bone Density in Adolescents Treated with a GnRH Agonist and Add-Back Therapy for Endometriosis
2007
A Longitudinal Assessment of Hormonal and Physical Alterations during Normal Puberty in Boys. V. Rising Leptin Levels May Signal the Onset of Puberty1
1997
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
Dairy and weight loss hypothesis: an evaluation of the clinical trials
2008
Essential oils: their antibacterial properties and potential applications in foods—a review
2004 Standout
Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: A double-blind placebo-controlled randomized trial
2015
Diagnosis of osteoporosis and assessment of fracture risk
2002 Standout
Changes in Diet and Lifestyle and Long-Term Weight Gain in Women and Men
2011 Standout
Exercise Standards for Testing and Training
2013 Standout
Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation
2009
Reporting on quality of life in randomised controlled trials: bibliographic study
1998
PATHOPHYSIOLOGY OF OSTEOPOROSIS
1998
Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society
2005
Sexual dimorphism of body composition
2007
The adolescent brain and age-related behavioral manifestations
2000 Standout
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 Standout
Mexican plants with hypoglycaemic effect used in the treatment of diabetes
2005 Standout
Bone Quality — The Material and Structural Basis of Bone Strength and Fragility
2006 Standout
Indigenous health part 1: determinants and disease patterns
2009
Osteoporosis: now and the future
2011 Standout
A Review on the Dietary Flavonoid Kaempferol
2011 Standout
Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures
2004
The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin
2002
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
2006 Standout
Treatment of Postmenopausal Osteoporosis
1998
Postmenopausal bone loss in Japanese women
1995 StandoutNobel
Rise and fall of anti-obesity drugs
2011
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
V. Meta-Analysis of the Efficacy of Hormone Replacement Therapy in Treating and Preventing Osteoporosis in Postmenopausal Women
2002
Uterine fibroids
2001 Standout
Weight Loss of Black, White, and Hispanic Men and Women in the Diabetes Prevention Program
2008
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Leptin Acts on Human Marrow Stromal Cells to Enhance Differentiation to Osteoblasts and to Inhibit Differentiation to Adipocytes1
1999
Oral Magnesium Supplementation Improves the Metabolic Profile of Metabolically Obese, Normal-weight Individuals: A Randomized Double-blind Placebo-controlled Trial
2014
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Endometriosis
2010 Standout
Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone
2014 StandoutNature
Silicon Supplementation Improves the Bone Mineral Density of Calcium-Deficient Ovariectomized Rats by Reducing Bone Resorption
2008
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function
2017 Standout
The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
2003 Standout
Hypoglycemic effect of Cecropia obtusifolia on streptozotocin diabetic rats
2001
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
1998 StandoutNature
Leptin and the regulation of body weight in mammals
1998 StandoutNature
Indigenous health part 2: the underlying causes of the health gap
2009 Standout
Global estimates of the prevalence of diabetes for 2010 and 2030
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Drug Treatment for Obesity in the Post-Sibutramine Era
2011
Safety, Efficacy, and Bioavailability of Fixed-Dose Combinations in Type 2 Diabetes Mellitus: A Systematic Updated Review
2017
A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata
1998
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
2000
Leptin Inhibits Bone Formation through a Hypothalamic Relay
2000 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Hypoglycemic effect of Acosmium panamense bark on streptozotocin diabetic rats
2003
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Magnesium in Man: Implications for Health and Disease
2014 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Vertebral fracture assessment using a semiquantitative technique
1993 Standout
Noninvasive assessment of bone mineral and structure: State of the art
1996
Diabetes in Bolivia
2001
Pharmacological and surgical treatment of obesity.
2004
Rodent models of diabetic cardiomyopathy
2009
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Birth and Death of Bone Cells: Basic Regulatory Mechanisms and Implications for the Pathogenesis and Treatment of Osteoporosis*
2000 Standout
Global Prevalence of Diabetes
2004 Standout
Predicting vertebral deformity using bone densitometry at various skeletal sites and calcaneus ultrasound
1995
Mechanisms of Diabetic Complications
2013 Standout
Guidelines for assessment of bone microstructure in rodents using micro–computed tomography
2010 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Comparisons of Noninvasive Bone Mineral Measurements in Assessing Age-Related Loss, Fracture Discrimination, and Diagnostic Classification
1997
Quantitative Ultrasound Techniques for the Assessment of Osteoporosis: Expert Agreement on Current Status
1997
Circulatory Status and Response to Cardiac Rehabilitation in Patients With Heart Failure
1996
Ovariectomy-Induced Bone Loss Varies Among Inbred Strains of Mice
2005
Maternal-Fetal Calcium and Bone Metabolism During Pregnancy, Puerperium, and Lactation*
1997
Works of M. Revilla being referenced
Prediabetes and its Relationship with Obesity in Mexican Adults: The Mexican Diabetes Prevention (MexDiab) Study
2008
Longitudinal study of the effect of calcium pidolate on bone mass in eugonadal women
1994
Total and regional bone mineral content in relation to menopause
1992
Influence of Body Mass Index on the Age-related Slope of Total and Regional Bone Mineral Content
1997
Body composition in children and Tanner's stages: A study with dual-energy x-ray absorptiometry
1993
Sex differences in the acquisition of total bone mineral mass peak assessed through dual-energy X-ray absorptiometry
1992
Influence of weight and gonadal status on total and regional bone mineral content and on weight-bearing and non-weight-bearing bones, measured by dual-energy X-ray absosorptiometry
1997
Zinc, Biochemical Markers of Nutrition, and Type I Osteoporosis
1995
Six‐Month Treatment of Obesity with Sibutramine 15 mg; A Double‐Blind, Placebo‐Controlled Monocenter Clinical Trial in a Hispanic Population
2000
Salmon calcitonin reduces vertebral fracture rate in postmenopausal crush fracture syndrome
1992
Hypoglycemic effect of Equisetum myriochaetum aerial parts on type 2 diabetic patients
2002
Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus
2008
Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: A prospective study
1995
The four-compartment models in body composition: Data from a study with dual-energy x-ray absorptiometry and near-infrared interactance on 815 normal subjects
1994
Cardiovascular Risk Factors and Acculturation in Yaquis and Tepehuanos Indians from Mexico
2008
Prophylaxis of osteoporosis with calcium, estrogens and/or eelcatonin: comparative longitudinal study of bone mass
1996
Hypoglycemic effect of Equisetum myriochaetum aerial parts on streptozotocin diabetic rats
2000
Cortical versus trabecular bone mass: Influence of activity on both bone components
1994
Metacarpal cortical thickness by computed radiography in osteoporosis
1994
Effects on bone loss of manganese alone or with copper supplement in ovariectomized rats
2000
Total and regional bone mineral content in women treated with GnRH agonists
1993
Heterogeneity of trabecular and cortical postmenopausal bone loss: A longitudinal study with pQCT
1997
Evidence that the loss of bone mass induced by GnRH agonists is not totally recovered
1995
Streptozotocin and Alloxan in Experimental Diabetes. Comparison of the Two Models in Rats.
2000
Ultrasound bone velocity and metacarpal radiogrametry in hemodialyzed patients.
1994
Crush fracture syndrome in senile osteoporosis: A nutritional consequence?
1992
Higher prevalence of diabetes in hypertensive subjects with upper body fat distribution.
1998
Effects of Zinc Supplementation on Vertebral and Femoral Bone Mass in Rats on Strenuous Treadmill Training Exercise
1998